To assess the biological impact of GPER1 activation on MM cells, we exploited the selective small molecule G-1, which has been previously demonstrated as a potent agonist of GPER1 in different tumor types [21,22,33]. This evidence concerns the gene GPER1 and Miyoshi myopathy.